Advanced Heart Failure and Transplant Cardiology · New Orleans, LA
NPI
1053726273
Since 2014
Specialty
Advanced Heart Failure and Transplant Cardiology
Code 207RA0001X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1514 Jefferson Hwy
New Orleans, LA, 70121
Phone (504) 842-4135
Groups this clinician bills Medicare through
Medicare paid, 2024
$35K
448 services
Medicare patients, 2024
165
Average age 65
Drug cost, 2024
$4.6M
3,420 prescriptions
Company payments, 2025
$42K
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Senthil Anand was code 93750 (external electrocardiographic monitoring), 68 times for 18 patients. In total Senthil Anand billed 448 services in 23 codes, and Medicare paid $35K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-04-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93750 External Electrocardiographic Monitoring | Facility | 68 | 18 | $30.63 | $2,083 |
| 99215 Office E&M - Established | Facility | 65 | 54 | $92.77 | $6,030 |
| 99233 Hospital E&M - Subsequent | Facility | 59 | 17 | $89.83 | $5,300 |
| 99214 Office E&M - Established | Facility | 56 | 52 | $74.32 | $4,162 |
| 99291 Critical Care E&M | Facility | 53 | 16 | $163.63 | $8,672 |
| 93451 Percutaneous Transcatheterization | Facility | 18 | 17 | $85.80 | $1,544 |
| 99205 Office E&M - New | Facility | 13 | 13 | $139.43 | $1,813 |
By year: 2022 $12K for 120 services; 2023 $28K for 314 services; 2024 $35K for 448 services.
Medicare prescription drug claims, 2024
In 2024, the drug Senthil Anand prescribed most often to Medicare patients was Entresto (Sacubitril/Valsartan), with 219 prescriptions and refills. In total Senthil Anand wrote 3,420 Medicare prescriptions that cost $4.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Entresto Sacubitril/Valsartan | 219 | 278 | 62 | $187K |
| Spironolactone Generic | 213 | 391 | 74 | $977 |
| Furosemide Generic | 178 | 271 | 56 | $497 |
| Jardiance Empagliflozin | 170 | 222 | 52 | $130K |
| Potassium Chloride Generic | 148 | 248 | 56 | $4,342 |
| Tacrolimus Generic | 132 | 180 | 26 | $16K |
| Atorvastatin Calcium Generic | 127 | 291 | 51 | $837 |
| Metoprolol Succinate Generic | 106 | 235 | 37 | $1,283 |
| Farxiga Dapagliflozin Propanediol | 98 | 130 | 23 | $71K |
| Bumetanide Generic | 95 | 157 | 29 | $4,090 |
| Pantoprazole Sodium Generic | 92 | 190 | 33 | $696 |
| Carvedilol Generic | 89 | 149 | 23 | $368 |
| Mycophenolate Mofetil Generic | 87 | 123 | 18 | $7,317 |
| Warfarin Sodium Generic | 86 | 142 | 26 | $817 |
| Torsemide Generic | 85 | 167 | 31 | $2,214 |
Brand drugs: - claims; generic drugs: 2,568 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Senthil Anand $42K ($42K in general payments such as food, travel and fees) from 18 companies. The largest payer was Merck Sharp & Dohme LLC with $23K.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 15 | $23K |
| Actelion Pharmaceuticals US, Inc. JNJ | 24 | $18K |
| Amgen Inc. AMGN | 1 | $119 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $104 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $103 |
| Liquidia Technologies, Inc. | 1 | $98.08 |
| Novo Nordisk Inc NVO | 3 | $79.3 |
| Johnson & Johnson Health Care Systems Inc. JNJ | 1 | $78.74 |
| BridgeBio Pharma, Inc. BBIO | 3 | $73.89 |
| Alnylam Pharmaceuticals Inc. ALNY | 2 | $69.73 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.